The 6 most recent market catalysts affecting $BLFS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Jul 27, 2026
Corporate Catalyst
Bearish
Impact 65
Stephens & Co. Downgrades BioLife Solutions to Equal-Weight, Lowers Price Target to $31
Stephens & Co. analyst Helfey Hannah downgraded BioLife Solutions (BLFS) from 'Overweight' to 'Equal-Weight' and lowered the price target from $32 to $31. This action signals a red…
Jul 23, 2026
Corporate Catalyst
Bearish
Impact 55
Jefferies Downgrades BioLife Solutions to Hold, Raises Price Target to $31
Jefferies analyst Matthew Stanton downgraded BioLife Solutions (BLFS) from a 'Buy' to a 'Hold' rating. This change in recommendation signals a more cautious outlook on the company'…
Jul 23, 2026
Corporate Catalyst
Bearish
Impact 65
TD Cowen Downgrades BioLife Solutions to Hold, Lowers Price Target to $31
TD Cowen analyst Brendan Smith downgraded BioLife Solutions from a 'Buy' to a 'Hold' rating and lowered the price target from $33 to $31. This action signals a less optimistic view…
Jul 23, 2026
Corporate Catalyst
Bearish
Impact 65
HC Wainwright & Co. Downgrades BioLife Solutions to Neutral, Lowers Price Target to $31
HC Wainwright & Co. analyst Yi Chen downgraded BioLife Solutions (BLFS) from a 'Buy' to a 'Neutral' rating and lowered the price target from $32 to $31. This action reflects a revi…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.